
Keywords: سیریوس; Eosinophils; biomarkers; severe eosinophilic asthma; DREAM; Dose Ranging Efficacy and safety With Mepolizumab in Severe Asthma; Feno; Fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; Inhaled corticosteroid; MENSA; Mepolizumab Adj